Qlaris sees double as drug reduces eye pressure in pair of phase 2 trials

[cafead]

via Qlaris Bio is seeing double when it comes to phase 2 wins for its eye drug, hitting the primary endpoints in trials that both spanned primary open angle glaucoma (POAG) and ocular hypertension (OHT).

article source